Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis [8]

Nephrology Dialysis Transplantation

Volumn 19, Issue 9, 2004, Pages 2423-2424

  Evrenkaya, T Rifki ^a   Atasoyu, Enes M ^a   Unver, Suat ^a   Basekim, Cinar ^a   Baloglu, Huseyin ^a   Tulbek, M Yasar ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFLAMMATORY AGENT; CHLORHEXIDINE GLUCONATE; CORTICOSTEROID; GELATINASE A; GELATINASE B; IMMUNOSUPPRESSIVE AGENT; METALLOPROTEINASE; PLASTICIZER; PREDNISOLONE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; VANCOMYCIN;

ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LAPAROTOMY; LETTER; MORTALITY; PERITONEAL BIOPSY; PRIORITY JOURNAL; REFLUX NEPHROPATHY; SCLEROSING PERITONITIS;

ALCOHOLS; CATHETERS, INDWELLING; CHLORHEXIDINE; DETERGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PREDNISOLONE; SCLEROSIS; TAMOXIFEN;

EID: 4544287651     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh150     Document Type: Letter

References (11)

1. Ishii Y, Sawada T, Shimizu A et al. An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 2001; 16: 1262-1266
2. Cancarini GC, Sandrini M, Vizzardi V et al. Clinical aspects of peritoneal sclerosis. J Nephrol 2001; 14 [Suppl 4]: 39-47
3. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12: 395-397
4. Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2001; 16: 1304-1305
5. Rajani R, Smyth J, Koffman CG et al. Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant 2002; 17: 2278-2280
6. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13: 154-159
7. Fagugli RM, Selvi A, Quintaliani G et al. Immunosuppressive treatment for sclerosing peritonitis. Nephrol Dial Transplant 1999; 14: 1343-1345
8. Junor BJR, Briggs JD, Forwell MA et al. Sclerosing peritonitis - the contribution of chlorhexidine in alcohol. Perit Dial Bull 1985; 5: 101-104
9. Nomoto Y, Kawaguchi Y, Kubo H et al. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28: 420-427
10. Ozener C, Kiris S, Lawrence R et al. Potential beneficial effect of tamoxifen in retroperitoneal fibrosis. Nephrol Dial Transplant 1997; 12: 2166-2168
11. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72kD progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 1989; 264: 1860-1869